doi: 10.1016/s0140-6736(73)90399-1.
Chemotherapeutic suppression of immune enhancement: a primary determinant of successful cancer therapy
- PMID: 4122012
- DOI: 10.1016/s0140-6736(73)90399-1
Item in Clipboard
Chemotherapeutic suppression of immune enhancement: a primary determinant of successful cancer therapy
Lancet.
.
No abstract available
Similar articles
-
[Fundamentals and tasks of immunosurgery].Bruns Beitr Klin Chir (1971). 1974 Apr;221(3):177-95. Bruns Beitr Klin Chir (1971). 1974. PMID: 4603550 Review. German. No abstract available.
-
Malignancy as a complication of immunosuppressive therapy.Adv Intern Med. 1971;17:95-123. Adv Intern Med. 1971. PMID: 4145004 Review. No abstract available.
-
The price of immunotherapy.Curr Probl Surg. 1981 Nov;18(11):681-751. doi: 10.1016/s0011-3840(81)80011-1. Curr Probl Surg. 1981. PMID: 6797793 Review. No abstract available.
-
Preclinical evaluation of the interrelationships between cancer chemotherapy and immunity.Natl Cancer Inst Monogr. 1971 Dec;34:90-102. Natl Cancer Inst Monogr. 1971. PMID: 4400958 Review. No abstract available.
-
[Immunological interrelationships of the body and the tumor].Vopr Onkol. 1975;21(10):93-102. Vopr Onkol. 1975. PMID: 52944 Review. Russian. No abstract available.
Cited by
-
Effect of treatment on the immunological status of women with advanced breast cancer.Br J Cancer. 1979 Jun;39(6):676-80. doi: 10.1038/bjc.1979.119. Br J Cancer. 1979. PMID: 444406 Free PMC article. Clinical Trial.
-
Letter: Suppressor cells and human malignant disease.Br Med J. 1976 May 1;1(6017):1072-3. doi: 10.1136/bmj.1.6017.1072-c. Br Med J. 1976. PMID: 1083758 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
